As high resistin levels in the first trimester of pregnancy (up to 36.55 ng/mL) have been associated with an increased risk of developing preeclampsia, it has been proposed that resistin concentration could be added to the predictive and prognostic algorithms for this pathology [62]. The gene discussed is RETN; the disease is preeclampsia.